With $70 million and a phase 2 ready asset in hand, British biotech Elevara Medicines has emerged to try to revolutionize the ...

This article was reviewed by Felix Gussone, MD. Low Testosterone and Joint Pain: What’s the Connection? Your knees, ankles, ...

CNW/ - UCB, a global biopharmaceutical leader committed to transforming the lives of patients with severe diseases, is ...